Akamis Bio raised $60 million in a Series A Prime financing led by Sedgwick Yard to advance its clinical candidate NG-350A for treating solid tumors.
Amount Raised
$60 Million
Round Type
Series A
Investors
Description
Akamis Bio announced $60 million in funding linked to the close of a Series A Prime financing round. The new funding will support the advancement of NG-350A through a Phase 1b clinical proof-of-concept study for patients with locally advanced rectal cancer.
Quick answer
Akamis Bio raised $60 Million in a Series A round, dated December 17, 2024. Investors: Sedgwick Yard.
- How much did Akamis Bio raise?
- Akamis Bio raised $60 Million in a Series A round on December 17, 2024.
- Who invested in Akamis Bio?
- Sedgwick Yard is named as investors in this round.
- What does Akamis Bio do?
- Akamis Bio is a clinical-stage oncology company whose mission is to leverage its groundbreaking Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to positively impact the lives of people living with cancer.
- Who are the decision-makers at Akamis Bio?
- Fundz holds 1 contact at Akamis Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as Akamis Bio that raised within 45 days of this round, from Fundz verified event records.
- Phlox Therapeutics raised $2M (Seed) on November 13, 2024.
- Diag-Nose.io raised $2M (Seed) on January 30, 2025.
- Atalanta Therapeutics raised $97M (Series B) on January 28, 2025.
- NRx Pharmaceuticals raised $3.5M (Seed) on January 27, 2025.
- Dermata Therapeutics raised $2.5M (Seed) on January 21, 2025.
- Phio Pharmaceuticals raised $153K (Seed) on January 17, 2025.
Who to call at Akamis Bio, and when
A new round usually means Akamis Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Akamis Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Akamis Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Akamis Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Akamis Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAkamis Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.